Printer Friendly

Isentress (Raltegravir) pricing: community sign-on letter.

The Fair Pricing Coalition is asking Merck to price its new and very important integrase inhibitor at a level everyone can live with. The letter is seeking organization and individual signers until the official launch of the drug, when the price will be announced.

"A new HIV drug produced by Merck is about to be approved by the Food & Drug Administration in early October. While this is great news, especially for people who have developed resistance to existing therapies, the pricing of this treatment will have a major impact on the various publicly funded programs like Medicaid, Medicare, and the AIDS Drug Assistance Program, all of which are already straining at the breaking point.

"Please join the Fair Pricing Coalition by signing onto the following statement to Merck...."

For the text of the letter and instructions for signing, visit
COPYRIGHT 2007 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:AIDS Treatment News
Date:Jul 1, 2007
Previous Article:New kind of antiretroviral, KP-1461; clinical trial recruiting. interview with Stephen Becker, M.D.
Next Article:AIDS Treatment News new toll-free phone number, 800-804-8845.

Related Articles
Community case of methicillin-resistant Staphylococcus aureus infection.
Community-associated Methicillin-resistant Staphylococcus aureus.
In vicious diatribe, Latvian cardinal distorts catholic teachings on homosexuality.
Certified coffee does the premium Pay off?
The war for the woods.
2007 City of Greater Sudbury's annual check-up.
T-Bay chamber acts as election watchdog.
Junior becomes miner with North Shore project.
Happy diamond mining for De Beers and Moose Cree.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters